UCSF Hematology, Blood & Marrow Transplant, and Cellular Therapy (HBC) Program

The UCSF Hematology, Blood & Marrow Transplant, and Cellular Therapy (HBC) Program, located at 400 Parnassus Avenue in San Francisco, California, is a renowned institution dedicated to providing advanced treatment options with care and compassion for patients with blood disorders and cancers. Patients from around the world seek treatment from our specialized providers, who offer innovative therapies and the opportunity to participate in cutting-edge clinical trials, including CAR T-cell therapy.

As part of the UCSF Helen Diller Family Comprehensive Cancer Center, our program offers a wide range of services to support cancer patients, including support groups, exercise classes, psychosocial support, and symptom management. Our research teams are at the forefront of cell-based immunotherapy for cancer, with a focus on developing breakthrough treatments for various blood cancers and solid tumors.

Our program is accredited by leading organizations such as the Foundation for Accreditation of Cellular Therapy (FACT) and the National Comprehensive Cancer Network, ensuring high-quality care and treatment for our patients. Additionally, we offer resources such as the Kôz Hospitality House for accommodations, mindfulness classes, chaplain services, interpreters in multiple languages, and patient liaisons to assist with international visitors.

Ranked as one of the top hospitals in the nation for cancer care, UCSF Hematology, Blood & Marrow Transplant, and Cellular Therapy Program is committed to providing exceptional care and support to patients undergoing challenging treatments such as bone marrow transplants and CAR T-cell therapy. Visit us for a comprehensive approach to cancer treatment and a compassionate, patient-centered experience."